Trial Profile

A First in Human, open label and single site evaluation of the safety, allergenicity and immunogenicity of ANG-101 in adult patients allergic to cat dander

Status: Completed

Phase of Trial: Phase I

Latest Information Update: 01 Feb 2024

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

29 Jan 2024 Results from this trial presented in an Angany media release.
29 Jan 2024 According to an Angany media release, company announced the completion on schedule of this study. Detailed results and conclusions of the study will be submitted to a top-tier scientific journal for publication. The results should also be presented at the EAACIs Annual Meeting to be held in Valencia in May 2024.
29 Jan 2024 Status changed to completed, according to an Angany media release.

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com